相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With Schizophrenia
T. Scott Stroup et al.
JAMA PSYCHIATRY (2019)
Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study
Sermin Toto et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis
Dan J. Siskind et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2018)
Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
Przemyslaw Duda et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
GSK-3β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1 Receptor Dysfunction in Schizophrenia
Jing-Ru Wang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2017)
Lithium Poisoning
Jonathan Baird-Gunning et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2017)
Boosting CNS axon regeneration by harnessing antagonistic effects of GSK3 activity
Marco Leibinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Sex/gender differences in the brain and cognition in schizophrenia
Adrianna Mendrek et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
A two-hit model of suicide-trait-related behaviors in the context of a schizophrenia-like phenotype: Distinct effects of lithium chloride and clozapine
Jessica Deslauriers et al.
PHYSIOLOGY & BEHAVIOR (2016)
Akting up in the GABA hypothesis of schizophrenia: Akt1 deficiency modulates GABAergic functions and hippocampus-dependent functions
Chia-Yuan Chang et al.
SCIENTIFIC REPORTS (2016)
Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers
Thomas Del' Guidice et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia
Ching-Hsun Huang et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Lithium for schizophrenia
Stefan Leucht et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Assessing Schizophrenia-relevant Cognitive and Social Deficits in Mice: A Selection of Mouse Behavioral Tasks and Potential Therapeutic Compounds
Wen-Sung Lai et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
A Sex- and Region-Specific Role of Akt1 in the Modulation of Methamphetamine-Induced Hyperlocomotion and Striatal Neuronal Activity: Implications in Schizophrenia and Methamphetamine-Induced Psychosis
Yi-Wen Chen et al.
SCHIZOPHRENIA BULLETIN (2014)
Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia
Adam R. Cole
FEBS JOURNAL (2013)
Continuous GSK-3β overexpression in the hippocampal dentate gyrus induces prodepressant-like effects and increases sensitivity to chronic mild stress in mice
Kerang Zhang et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
GSK-3β Polymorphism Discriminates Bipolar Disorder and Schizophrenia: A Systematic Meta-Analysis
Hui Tang et al.
MOLECULAR NEUROBIOLOGY (2013)
Lithium normalizes amphetamine-induced changes in striatal FoxO1 phosphorylation and behaviors in rats
Wenhua Zheng et al.
NEUROREPORT (2013)
Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice
Junichi Kitanaka et al.
BRAIN RESEARCH (2012)
Successful Combined Therapy with Tamoxifen and Lithium in a Paradoxical Sleep Deprivation-Induced Mania Model
Fernanda Armani et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Akt1 deficiency modulates reward learning and reward prediction error in mice
Y. -C. Chen et al.
GENES BRAIN AND BEHAVIOR (2012)
A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health
Jean-Martin Beaulieu
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2012)
Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications
H. Y. Tan et al.
MOLECULAR PSYCHIATRY (2012)
Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release
Yukio Ago et al.
NEUROPHARMACOLOGY (2012)
Inhibition of GSK3 by lithium, from single molecules to signaling networks
Laure Freland et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
BEHAVIORAL PHENOTYPING OF V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1-DEFICIENT MICE REVEALS A SEX-SPECIFIC PREPULSE INHIBITION DEFICIT IN FEMALES THAT CAN BE PARTIALLY ALLEVIATED BY GLYCOGEN SYNTHASE KINASE-3 INHIBITORS BUT NOT BY ANTIPSYCHOTICS
Y. W. Chen et al.
NEUROSCIENCE (2011)
GSK-3 beta activity and hyperdopamine-dependent behaviors
Yan-Chun Li et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
DISC1 regulates synaptic vesicle transport via a lithium-sensitive pathway
Rafael Flores et al.
NEUROSCIENCE RESEARCH (2011)
Genetic association and identification of a functional SNP at GSK3β for schizophrenia susceptibility
Ming Li et al.
SCHIZOPHRENIA RESEARCH (2011)
Polypharmacy in schizophrenia
Mathias Zink et al.
CURRENT OPINION IN PSYCHIATRY (2010)
GSK3 signalling in neural development
Eun-Mi Hur et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Pretreatment with L-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice
Junichi Kitanaka et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Prepulse inhibition and genetic mouse models of schizophrenia
Susan B. Powell et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis
Rodrigo Machado-Vieira et al.
BIPOLAR DISORDERS (2009)
Involvement of Akt in neurite outgrowth
Danielle E. Read et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Update on key previously proposed candidate genes for schizophrenia
Sibylle G. Schwab et al.
CURRENT OPINION IN PSYCHIATRY (2009)
Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?
Leslie Citrome
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Selective induction of neocortical GABAergic neurons by the PDK1-Akt pathway through activation of Mash1
Koji Oishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families
Dawn L. Thiselton et al.
BIOLOGICAL PSYCHIATRY (2008)
A β-arrestin 2 signaling complex mediates lithium action on Behavior
Jean-Martin Beaulieu et al.
CELL (2008)
Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans
Hao-Yang Tan et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS
John Dill et al.
JOURNAL OF NEUROSCIENCE (2008)
Association of AKT1 gene Polymorphisms with risk of schizophrenia and with response to Antipsychotics in the chinese population
Ming-Qing Xu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
GSK3 alpha and GSK3 beta are necessary for axon formation
Juan Jose Garrido et al.
FEBS LETTERS (2007)
Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival
Min-Huei Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics
Kelley C. O'Donnell et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)
The Akt-GSK-3 signaling cascade in the actions of doparnine
Jean-Martin Beaulieu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning
Wen-Sung Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions
Richard S. Jope et al.
CURRENT DRUG TARGETS (2006)
Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania
Benicio N. Frey et al.
LIFE SCIENCES (2006)
Association of AKT1 haplotype with the risk of schizophrenia in Iranian population
Sepideh N. Bajestan et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2006)
Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction
Zhong Zhao et al.
SCHIZOPHRENIA RESEARCH (2006)
An update on the genetics of schizophrenia
N Norton et al.
CURRENT OPINION IN PSYCHIATRY (2006)
Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families
SG Schwab et al.
BIOLOGICAL PSYCHIATRY (2005)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
JM Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Safety and efficacy of combined clozapine-lithium pharmacotherapy
S Bender et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
ES Emamian et al.
NATURE GENETICS (2004)
Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium
WT O'Brien et al.
JOURNAL OF NEUROSCIENCE (2004)
Association of AKT1 with schizophrenia confirmed in a Japanese population
M Ikeda et al.
BIOLOGICAL PSYCHIATRY (2004)
Genetic correlational analysis of glycogen synthase kinase-3β and prepulse inhibition in inbred mice
S Amar et al.
GENES BRAIN AND BEHAVIOR (2004)
Sex differences in the risk of schizophrenia - Evidence from meta-analysis
A Aleman et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium
P De Sarno et al.
NEUROPHARMACOLOGY (2002)
Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges
NR Swerdlow et al.
PSYCHOPHARMACOLOGY (2001)
Prepulse inhibition of the startle response in men with schizophrenia -: Effects of age of onset of illness, symptoms, and medication
V Kumari et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Animal models for the negative symptoms of schizophrenia
BA Ellenbroek et al.
BEHAVIOURAL PHARMACOLOGY (2000)
分享论文
